News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antares Pharma, Inc. (AIS) Announces Podium Presentation of Pivotal OTREXUP™ (methotrexate) Data at American College of Rheumatology Annual Meeting


10/16/2013 6:40:53 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that data from a pivotal clinical trial of OTREXUP™ (methotrexate) for subcutaneous injection were selected for live, oral presentation during a clinical treatment strategies sub-session of the 2013 American College of Rheumatology (ACR) Annual Meeting, in San Diego.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES